AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] PDF Solutions Inc Reports Material Event

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Form 4 snapshot: On 06/25/2025, Todd M. Duchene, Chief Legal and Administrative Officer of Core Scientific, Inc. (CORZZ), sold 7,759 common shares at $12.391 each. The sale—valued at roughly $96 thousand—was executed under a pre-existing instruction to cover withholding taxes triggered by the vesting of restricted stock units.

After the disposition, Duchene continues to hold 2,049,689 shares directly.

The filing also discloses that on 06/17/2025 he received 7,346 shares at no cost via an in-kind pro-rata distribution from shares reserved for claims settlement stemming from the company’s prior bankruptcy proceedings. That receipt was exempt from Section 16 reporting under Rule 16a-9.

No derivative transactions or additional insider trades were reported in this filing.

Sintesi del Modulo 4: Il 25/06/2025, Todd M. Duchene, Direttore Legale e Amministrativo di Core Scientific, Inc. (CORZZ), ha venduto 7.759 azioni ordinarie a 12,391 $ ciascuna. La vendita, del valore di circa 96 mila dollari, è stata eseguita in base a un'istruzione preesistente per coprire le tasse di ritenuta derivanti dal consolidamento delle unità azionarie vincolate.

Dopo la vendita, Duchene detiene ancora direttamente 2.049.689 azioni.

La comunicazione riporta anche che il 17/06/2025 ha ricevuto 7.346 azioni gratuitamente tramite una distribuzione proporzionale in natura da azioni riservate per la liquidazione di reclami legati alle precedenti procedure fallimentari della società. Tale ricezione è esente dalla segnalazione ai sensi della Sezione 16 secondo la Regola 16a-9.

Non sono state segnalate transazioni derivate né ulteriori operazioni da parte di insider in questo modulo.

Resumen del Formulario 4: El 25/06/2025, Todd M. Duchene, Director Legal y Administrativo de Core Scientific, Inc. (CORZZ), vendió 7,759 acciones ordinarias a $12.391 cada una. La venta, valorada en aproximadamente 96 mil dólares, se realizó bajo una instrucción preexistente para cubrir los impuestos retenidos generados por la consolidación de unidades restringidas de acciones.

Tras la venta, Duchene sigue poseyendo directamente 2,049,689 acciones.

El informe también revela que el 17/06/2025 recibió 7,346 acciones sin costo mediante una distribución prorrata en especie de acciones reservadas para la liquidación de reclamaciones derivadas de procedimientos concursales previos de la empresa. Esta recepción estuvo exenta de reporte según la Sección 16 bajo la Regla 16a-9.

No se reportaron transacciones derivadas ni operaciones adicionales de insiders en este informe.

Form 4 요약: 2025ë…� 6ì›� 25ì�, Core Scientific, Inc.(CORZZ)ì� 최고 법률 ë°� 행정 ì±…ìž„ìž� Todd M. Ducheneê°€ 보통ì£� 7,759주를 주당 12.391달러ì—� 매ë„했습니다. ì•� 9ë§� 6ì²� 달러 규모ì� ì´ë²ˆ 매ë„ëŠ� 제한 ì£¼ì‹ ë‹¨ìœ„ì� 권리 확정으로 ë°œìƒí•� ì›ì²œì§•수세를 충당하기 위한 기존 ì§€ì‹œì— ë”°ë¼ ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�.

ë§¤ë„ í›� DucheneëŠ� ì§ì ‘ 2,049,689주를 ê³„ì† ë³´ìœ í•˜ê³  있습니다.

ë˜í•œ 해당 신고서ì—ëŠ� 2025ë…� 6ì›� 17ì¼ì— 회사ì� ì´ì „ 파산 절차ì—서 ë°œìƒí•� 청구 í•´ê²°ì� 위해 예약ë� 주ì‹ì—서 현물 비례 ë°°ë¶„ ë°©ì‹ìœ¼ë¡œ 7,346주를 무ìƒìœ¼ë¡œ 수령했으ë©�, ì� ìˆ˜ë ¹ì€ Rule 16a-9ì—� 따른 섹션 16 ë³´ê³  ë©´ì œ 대ìƒìž„ì� ë°í˜€ì¡ŒìŠµë‹ˆë‹¤.

ì´ë²ˆ 신고서ì—ëŠ� íŒŒìƒ ê±°ëž˜ë‚� 추가 ë‚´ë¶€ìž� 거래ëŠ� ë³´ê³ ë˜ì§€ 않았습니ë‹�.

Résumé du formulaire 4 : Le 25/06/2025, Todd M. Duchene, Directeur juridique et administratif de Core Scientific, Inc. (CORZZ), a vendu 7 759 actions ordinaires à 12,391 $ chacune. La vente � d'une valeur d'environ 96 000 $ � a été réalisée conformément à une instruction préexistante visant à couvrir les taxes à la source générées par l'acquisition des unités d'actions restreintes.

Après cette opération, Duchene détient encore directement 2 049 689 actions.

Le dépôt révèle également que le 17/06/2025, il a reçu 7 346 actions gratuitement via une distribution en nature au prorata provenant d'actions réservées pour le règlement de créances liées aux procédures de faillite antérieures de la société. Cette réception était exonérée de déclaration au titre de la Section 16 selon la Règle 16a-9.

Aucune transaction dérivée ni autre opération d'initié n'ont été signalées dans ce dépôt.

Formular 4 Zusammenfassung: Am 25.06.2025 verkaufte Todd M. Duchene, Chief Legal and Administrative Officer von Core Scientific, Inc. (CORZZ), 7.759 Stammaktien zu je 12,391 $. Der Verkauf � im Wert von etwa 96.000 $ � erfolgte aufgrund einer vorbestehenden Anweisung zur Deckung von Quellensteuern, die durch die Vesting von Restricted Stock Units ausgelöst wurden.

Nach der Veräußerung hält Duchene weiterhin 2.049.689 Aktien direkt.

Die Einreichung gibt außerdem bekannt, dass er am 17.06.2025 7.346 Aktien kostenfrei im Rahmen einer anteiligen Sachdividende aus Aktien, die für die Begleichung von Forderungen aus früheren Insolvenzverfahren des Unternehmens reserviert waren, erhalten hat. Dieser Erhalt war gemäß Regel 16a-9 von der Meldepflicht nach Abschnitt 16 ausgenommen.

Es wurden keine Derivatgeschäfte oder weitere Insidertransaktionen in dieser Meldung berichtet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Minor tax-related insider sale; ownership remains high—little immediate valuation impact.

The 7,759-share sale represents less than 0.4 % of Mr. Duchene’s reported direct holdings and is immaterial relative to Core Scientific’s total shares outstanding. The stated purpose—covering tax obligations—reduces concerns about discretionary unloading. The officer still controls >2 million shares, signalling continued alignment with shareholders. Given the company’s recent emergence from bankruptcy, the separate 7,346-share settlement distribution is largely administrative. Overall, I view the filing as neutral with negligible influence on near-term share price.

TL;DR: Routine Section 16 filing, no governance red flags detected.

The transaction was executed under a documented plan, satisfying best-practice Rule 10b5-1 safeguards and reinforcing transparency. The tax-withholding rationale is common for RSU vesting events, and the subsequent holding size suggests the insider’s economic interest remains substantial. The bankruptcy-related share distribution was pre-structured and exempt, indicating procedural compliance. Consequently, the disclosure does not alter the governance risk profile and is not materially impactful for investors.

Sintesi del Modulo 4: Il 25/06/2025, Todd M. Duchene, Direttore Legale e Amministrativo di Core Scientific, Inc. (CORZZ), ha venduto 7.759 azioni ordinarie a 12,391 $ ciascuna. La vendita, del valore di circa 96 mila dollari, è stata eseguita in base a un'istruzione preesistente per coprire le tasse di ritenuta derivanti dal consolidamento delle unità azionarie vincolate.

Dopo la vendita, Duchene detiene ancora direttamente 2.049.689 azioni.

La comunicazione riporta anche che il 17/06/2025 ha ricevuto 7.346 azioni gratuitamente tramite una distribuzione proporzionale in natura da azioni riservate per la liquidazione di reclami legati alle precedenti procedure fallimentari della società. Tale ricezione è esente dalla segnalazione ai sensi della Sezione 16 secondo la Regola 16a-9.

Non sono state segnalate transazioni derivate né ulteriori operazioni da parte di insider in questo modulo.

Resumen del Formulario 4: El 25/06/2025, Todd M. Duchene, Director Legal y Administrativo de Core Scientific, Inc. (CORZZ), vendió 7,759 acciones ordinarias a $12.391 cada una. La venta, valorada en aproximadamente 96 mil dólares, se realizó bajo una instrucción preexistente para cubrir los impuestos retenidos generados por la consolidación de unidades restringidas de acciones.

Tras la venta, Duchene sigue poseyendo directamente 2,049,689 acciones.

El informe también revela que el 17/06/2025 recibió 7,346 acciones sin costo mediante una distribución prorrata en especie de acciones reservadas para la liquidación de reclamaciones derivadas de procedimientos concursales previos de la empresa. Esta recepción estuvo exenta de reporte según la Sección 16 bajo la Regla 16a-9.

No se reportaron transacciones derivadas ni operaciones adicionales de insiders en este informe.

Form 4 요약: 2025ë…� 6ì›� 25ì�, Core Scientific, Inc.(CORZZ)ì� 최고 법률 ë°� 행정 ì±…ìž„ìž� Todd M. Ducheneê°€ 보통ì£� 7,759주를 주당 12.391달러ì—� 매ë„했습니다. ì•� 9ë§� 6ì²� 달러 규모ì� ì´ë²ˆ 매ë„ëŠ� 제한 ì£¼ì‹ ë‹¨ìœ„ì� 권리 확정으로 ë°œìƒí•� ì›ì²œì§•수세를 충당하기 위한 기존 ì§€ì‹œì— ë”°ë¼ ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�.

ë§¤ë„ í›� DucheneëŠ� ì§ì ‘ 2,049,689주를 ê³„ì† ë³´ìœ í•˜ê³  있습니다.

ë˜í•œ 해당 신고서ì—ëŠ� 2025ë…� 6ì›� 17ì¼ì— 회사ì� ì´ì „ 파산 절차ì—서 ë°œìƒí•� 청구 í•´ê²°ì� 위해 예약ë� 주ì‹ì—서 현물 비례 ë°°ë¶„ ë°©ì‹ìœ¼ë¡œ 7,346주를 무ìƒìœ¼ë¡œ 수령했으ë©�, ì� ìˆ˜ë ¹ì€ Rule 16a-9ì—� 따른 섹션 16 ë³´ê³  ë©´ì œ 대ìƒìž„ì� ë°í˜€ì¡ŒìŠµë‹ˆë‹¤.

ì´ë²ˆ 신고서ì—ëŠ� íŒŒìƒ ê±°ëž˜ë‚� 추가 ë‚´ë¶€ìž� 거래ëŠ� ë³´ê³ ë˜ì§€ 않았습니ë‹�.

Résumé du formulaire 4 : Le 25/06/2025, Todd M. Duchene, Directeur juridique et administratif de Core Scientific, Inc. (CORZZ), a vendu 7 759 actions ordinaires à 12,391 $ chacune. La vente � d'une valeur d'environ 96 000 $ � a été réalisée conformément à une instruction préexistante visant à couvrir les taxes à la source générées par l'acquisition des unités d'actions restreintes.

Après cette opération, Duchene détient encore directement 2 049 689 actions.

Le dépôt révèle également que le 17/06/2025, il a reçu 7 346 actions gratuitement via une distribution en nature au prorata provenant d'actions réservées pour le règlement de créances liées aux procédures de faillite antérieures de la société. Cette réception était exonérée de déclaration au titre de la Section 16 selon la Règle 16a-9.

Aucune transaction dérivée ni autre opération d'initié n'ont été signalées dans ce dépôt.

Formular 4 Zusammenfassung: Am 25.06.2025 verkaufte Todd M. Duchene, Chief Legal and Administrative Officer von Core Scientific, Inc. (CORZZ), 7.759 Stammaktien zu je 12,391 $. Der Verkauf � im Wert von etwa 96.000 $ � erfolgte aufgrund einer vorbestehenden Anweisung zur Deckung von Quellensteuern, die durch die Vesting von Restricted Stock Units ausgelöst wurden.

Nach der Veräußerung hält Duchene weiterhin 2.049.689 Aktien direkt.

Die Einreichung gibt außerdem bekannt, dass er am 17.06.2025 7.346 Aktien kostenfrei im Rahmen einer anteiligen Sachdividende aus Aktien, die für die Begleichung von Forderungen aus früheren Insolvenzverfahren des Unternehmens reserviert waren, erhalten hat. Dieser Erhalt war gemäß Regel 16a-9 von der Meldepflicht nach Abschnitt 16 ausgenommen.

Es wurden keine Derivatgeschäfte oder weitere Insidertransaktionen in dieser Meldung berichtet.

false 0001120914 0001120914 2025-06-17 2025-06-17
 
Table of Contents


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of Earliest Event Reported): June 17, 2025
 
PDF SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
 
000-31311
(Commission File Number)
 
Delaware
25-1701361
(State or Other Jurisdiction of Incorporation)
(I.R.S. Employer Identification No.)
 
2858 De La Cruz Boulevard
Santa Clara, CA 95050
(Address of principal executive offices, with zip code)
 
(408) 280-7900
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Exchange Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.00015 par value
PDFS
The NASDAQ Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 


 
 

 
TABLE OF CONTENTS
 
Item 5.07.
Submission of Matters to a Vote of Security Holders.
Item 9.01.
Financial Statements and Exhibits
SIGNATURES
 
 

 
Item 5.07. Submission of Matters to a Vote of Security Holders.
 
On June 17, 2025, at the 2025 Annual Meeting of Stockholders, the stockholders of the Company elected each of the director nominees and approved proposals 2, 3, 4, and 5.
 
The final results for the votes regarding each proposal are set forth below. The proposals are described in detail in the Company’s Proxy Statement.
 
Proposal No. 1 Election of Class III Directors:
 
NOMINEES FOR
CLASS II
DIRECTORS
FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
Nancy Erba
28,081,951 1,271,859 4,073 3,995,611
Michael B. Gustafson
28,053,621 1,282,956 21,306 3,995,611
John Kibarian, Ph.D.
27,980,796 1,373,014 4,073 3,995,611
 
Proposal No. 2 Ratification of the appointment of BPM LLP as the Independent Registered Public Accounting Firm for the Company for the year ending December 31, 2025:
 
FOR
AGAINST
ABSTAIN
32,953,889 20,009 379,596
 
Proposal No. 3 Approval of the Companys Tenth Amended and Restated 2011 Stock Incentive Plan:
 
FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
28,927,482 424,547 5,854 3,995,611
 
Proposal No. 4 Approval of the Company's Second Amended and Restated 2021 Employee Stock Purchase Plan
 
FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
29,326,223
25,056
6,604 3,995,611
 
Proposal No. 5 Approval, by non-binding advisory vote, of the 2024 compensation awarded to Named Executive Officers:
 
FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
29,032,173 237,726 87,984 3,995,611
 
 

 
 
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
 
10.1
 
PDF Solutions, Inc.’s Tenth Amended and Restated 2011 Stock Incentive Plan
10.2
 
PDF Solutions, Inc.’s Second Amended and Restated 2021 Employee Stock Purchase Plan
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
† Management contract or compensatory plan arrangement.
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
PDF SOLUTIONS, INC.
(Registrant)
     
 
By:
/s/ Adnan Raza
   
Adnan Raza
   
EVP, Finance, and Chief Financial Officer
(principal financial and accounting officer)
 
Dated: June 23, 2025
 
 
Pdf Solutions

NASDAQ:PDFS

PDFS Rankings

PDFS Latest News

PDFS Latest SEC Filings

PDFS Stock Data

927.61M
31.48M
19.39%
73.66%
1.47%
Software - Application
Services-prepackaged Software
United States
SANTA CLARA